
Mazdutide
CAS: 2259884-03-0
Mazdutide is a research peptide in the glp-1 / weight management category. Mazdutide is a dual GLP-1 and glucagon receptor agonist derived from the gut peptide hormone oxyntomodulin. MiPeptidos offers Mazdutide in 1 sizes with 99.4% verified purity and full analytical documentation.
How Mazdutide Works
Mazdutide is a dual GLP-1 and glucagon receptor agonist derived from the gut peptide hormone oxyntomodulin. It activates GLP-1 receptors to promote insulin secretion and suppress appetite, while simultaneously activating glucagon receptors to increase energy expenditure and promote hepatic lipid catabolism. The acylated peptide structure enables albumin binding and extended systemic exposure.
Research Applications
Pricing
| Size | Per Vial | 10-Pack |
|---|---|---|
10mg | $109.95 | $802.95 |
Prices shown per vial from 10-pack. Volume discounts available for 50+ vials — contact us.
HPLC Purity Analysis
Certificate of Analysis
This COA is a representative sample. A batch-specific Certificate of Analysis with full HPLC chromatograms and mass spectrometry data is included with every MiPeptidos order.
Reconstitution Calculator
Inject bacteriostatic water slowly along the vial wall. Gently swirl until dissolved — never shake. Store reconstituted solution at 2-8°C and use within 30 days.
Download Product Brochure
Get our detailed Mazdutide product brochure with specifications, research applications, HPLC analysis data, and reconstitution guide. Available in English and Spanish.
Customer Reviews
Frequently Asked Questions
Specifications
Sequence
Synthetic oxyntomodulin-derived peptide; dual GLP-1/glucagon receptor agonist with fatty acid acylation for extended half-life
Research Use Only. This product is intended for laboratory research purposes only. Not for human consumption. Handle with appropriate safety precautions.
Related Peptides

Semaglutide
A glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for glycemic control. Widely studied for its role in appetite regulation and metabolic research.

Tirzepatide
A dual GIP/GLP-1 receptor agonist studied for its effects on glucose metabolism and body weight regulation. One of the most researched peptides in the incretin class.

Retatrutide
A triple agonist targeting GIP, GLP-1, and glucagon receptors. Investigated in preclinical and clinical research for its multi-pathway approach to metabolic regulation.

Liraglutide
A GLP-1 receptor agonist with an extended half-life due to fatty acid acylation. Extensively studied for glucose homeostasis and appetite signaling research.